Here’s whether Acadia Healthcare Company, Inc. (ACHC) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+0.60% over 10 days); RSI 42 — healthy momentum range. Concerns: below the 50-day MA (medium-term momentum negative). Currently 18.9% off its 52-week high. Score: +3/7.
ACHC is holding above its long-term 200-day MA ($20.79) but has slipped below the 50-day MA ($25.53), pointing to short-term weakness in an otherwise intact trend. An RSI of 42.2 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +8.2% compares to +24.4% for SPY (trailed the market by 16.2%).
$10,000 invested 1 year ago→ $10,817 today
vs. S&P 500 (SPY) — same period trailed market by 16.2%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($20.79)
✗Above 50-day MA ($25.53)
✓RSI(14) neutral zone (30–70) — currently 42.2
✓Positive return (+8.2%)
!Within 10% of period high (−18.9%)
Period Range $24.48
$11.43$30.20
RSI (14) 42.2
0 · OversoldOverbought · 100
Key Metrics
Price$24.48
Period Return+8.2%
Period High$30.20
Period Low$11.43
Drawdown−18.9%
MA-50$25.53
MA-200$20.79
RSI (14)42.2
Avg Volume (30d)3.0M
vs. SPYtrailed by 16.2%
Return Rank#636 of 1245
Trend Signals
Price is above the 200-day moving average ($20.79)